Prestige Consumer Healthcare Inc. (PBH) stock
PBHNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3021% below fair value
$50.62+2.40 (+4.98%)
Close on Nov 18, 2026Market cap $2.40BP/E 14.2Yield –
Prestige Consumer Healthcare pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Prestige Consumer Healthcare's pe ratio was 12.4× on Nov 11, 2026, against 14.8× a year earlier. Over the last 5 years it ranged from 10.8× to 20.6×, with a median of 15.3×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 12.4× | −2.9 |
| 2025 | Dec 31, 2025 | 15.3× | −3.7 |
| 2024 | Dec 31, 2024 | 19.0× | +4.2 |
| 2023 | Apr 28, 2023 | 14.8× | −0.4 |
| 2022 | Dec 30, 2022 | 15.2× | −1.9 |
| 2021 | Dec 31, 2021 | 17.1× | +6.3 |
| 2020 | Dec 31, 2020 | 10.8× | −13.3 |
| 2019 | Apr 30, 2019 | 24.1× | +19.3 |
| 2018 | Dec 31, 2018 | 4.8× | −17.4 |
| 2017 | Dec 29, 2017 | 22.2× | −18.2 |
| 2016 | Dec 30, 2016 | 40.4× | +13.9 |
| 2015 | Dec 31, 2015 | 26.5× | −8.5 |
| 2014 | Dec 31, 2014 | 35.1× | +13.2 |
| 2013 | Dec 31, 2013 | 21.8× | −1.5 |
| 2012 | Dec 31, 2012 | 23.3× | +7.6 |
| 2011 | Dec 30, 2011 | 15.7× | −3.0 |
| 2010 | Dec 31, 2010 | 18.7× | – |
See a number that looks wrong?